US pharma major, Johnson & Johnson has applied for the Emergency Use Authorisation (EUA) of its single-dose Covid-19 vaccine named Janessen. In an official statement issued by the company on Friday, it said, "On August 5, 2021, Johnson & Johnson Pvt. Ltd applied for EUA of its single-dose covid-19 vaccine to the Government of India." J&J has claimed that its single-shot vaccine, in clinical trials, proved to be 85 per cent effective in preventing severe disease. The vaccine also showed protection against Covid-19 related hospitalisation and death, it said.